Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Market Cap	894.83B
Revenue (ttm)	586.15B
Net Income (ttm)	-2.48B
Shares Out	31.51M
EPS (ttm)	-88.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,023,389
Average Volume	3,138,266
Open	27,550
Previous Close	26,650
Day's Range	27,400 - 31,550
52-Week Range	10,300 - 34,700
Beta	1.07
RSI	60.96
Earnings Date	Oct 30, 2025

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 1,067
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 249420

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.